This proposal is for a competitive renewal of the University of Rochester Alzheimer's Disease Center (ADC). This Center is just starting its fourth year of existence. The ADC was preceded by a Program directed at morphological, neurochemical and molecular studies of AD and normal control human brain. These four years have been a time of transition from the program project structure which was oriented around providing well characterized human brains for a limited stet of basic neurobiological studies to the broader scope of an ADC. This ADC contains four cores; 1) Administrative, including Pilot Projects, 2) Clinical, including two satellite Diagnostic & Treatment Centers (SDTC - one Urban and one Rural), 3) Neuropathology and Brain Bank and 4) Education & Information Transfer. The Center Director reports to the Dean, School of medicine and Dentistry. The Core Directors report to the Director and Associate Director of the ADC. The ADC represents a successful and meaningful cooperative effort among a number of departments of the University of Rochester Medical Center, affiliated hospitals, clinics, regional hospitals, area nursing homes and community service organizations, all directed at occasioning cases to the ADC. A major aspect of the transition from program project to ADC has resolved around broadening the base from which patients will be drawn, both through the SDTCs as well as through expansion of the sites monitored by the Clinical Core. Another aspect of the transition has been the addition of a neurological disease control group - multi-infarct dementia. In addition, the ADC is designed to serve a broader range of studies, particularly into the area of clinical studies and trials of therapeutic interventions. The neuropathologic examination of brains has been broadened, particularly to distinguish lewy bodies and plaque subtypes. In addition, the Neuropathology Core proposed to provide randomly sampled counts of senile plaques and neurofibrillary tangles from selected brain regions for correlation with basic science studies. These counts will be in addition to counts obtained for the Khachaturian diagnostic criteria.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008665-09
Application #
2699757
Study Section
Special Emphasis Panel (ZAG1-MBM-5 (02))
Project Start
1990-08-15
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Rochester
Department
Neurosciences
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Chapman, Robert M; Gardner, Margaret N; Mapstone, Mark et al. (2015) Memory timeline: Brain ERP C250 (not P300) is an early biomarker of short-term storage. Brain Res 1604:74-83
Chapman, Robert M; Porsteinsson, Anton P; Gardner, Margaret N et al. (2013) C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease. J Alzheimers Dis 33:55-68
Chapman, Robert M; Mapstone, Mark; Gardner, Margaret N et al. (2011) Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc 17:654-62
Chapman, Robert M; Mapstone, Mark; McCrary, John W et al. (2011) Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods. J Clin Exp Neuropsychol 33:187-99
Chapman, Robert M; McCrary, John W; Gardner, Margaret N et al. (2011) Brain ERP components predict which individuals progress to Alzheimer's disease and which do not. Neurobiol Aging 32:1742-55
Chapman, Robert M; Mapstone, Mark; Porsteinsson, Anton P et al. (2010) Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses. J Clin Exp Neuropsychol 32:793-808
Price, Joseph L; McKeel Jr, Daniel W; Buckles, Virginia D et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026-36
Chapman, Robert M; Nowlis, Geoffrey H; McCrary, John W et al. (2007) Brain event-related potentials: diagnosing early-stage Alzheimer's disease. Neurobiol Aging 28:194-201
Hurley, Sean D; Coleman, Paul D (2003) Facial nerve axotomy in aged and young adult rats: analysis of the glial response. Neurobiol Aging 24:511-8
Porsteinsson, Anton P; Tariot, Pierre N; Jakimovich, Laura J et al. (2003) Valproate therapy for agitation in dementia: open-label extension of a double-blind trial. Am J Geriatr Psychiatry 11:434-40

Showing the most recent 10 out of 66 publications